Nomenclature for human CYP2D6 alleles

被引:382
|
作者
Daly, AK
Brockmoller, J
Broly, F
Eichelbaum, M
Evans, WE
Gonzalez, FJ
Huang, JD
Idle, JR
IngelmanSundberg, M
Ishizaki, T
JacqzAigrain, E
Meyer, UA
Nebert, DW
Steen, VM
Wolf, CR
Zanger, UM
机构
[1] HUMBOLDT UNIV BERLIN, INST KLIN PHARMAKOL, KLINIKUM CHARITE, D-10098 BERLIN, GERMANY
[2] CTR HOSP REG & UNIV LILLE, HOP CALMETTE, LAB BIOCHIM & BIOL MOL, F-59037 LILLE, FRANCE
[3] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL, D-70376 STUTTGART, GERMANY
[4] ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT, MEMPHIS, TN 38101 USA
[5] NCI, MOLEC CARCINOGENESIS LAB, NIH, BETHESDA, MD 20892 USA
[6] NATL CHENG KUNG UNIV, DEPT PHARMACOL, TAINAN 70101, TAIWAN
[7] KAROLINSKA INST, DEPT MED BIOCHEM & BIOPHYS, S-17177 STOCKHOLM, SWEDEN
[8] INT MED CTR JAPAN, RES INST, DEPT CLIN PHARMACOL, SHINJUKU KU, TOKYO 162, JAPAN
[9] HOP ROBERT DEBRE, INSERM U120, F-75019 PARIS, FRANCE
[10] HOP ROBERT DEBRE, DEPT CLIN PHARMACOL, F-75019 PARIS, FRANCE
[11] UNIV BASEL, BIOCTR, ABT PHARMAKOL, CH-4056 BASEL, SWITZERLAND
[12] UNIV CINCINNATI, MED CTR, DEPT ENVIRONM HLTH, CINCINNATI, OH 45267 USA
[13] HAUKELAND HOSP, CTR MOL MED, DR EINAR MARTENS RES GRP BIOL PSYCHIAT, N-5021 BERGEN, NORWAY
[14] UNIV DUNDEE, NINEWELLS HOSP & MED SCH, BIOMED RES CTR, DUNDEE DD1 9SY, SCOTLAND
来源
PHARMACOGENETICS | 1996年 / 6卷 / 03期
关键词
allele nomenclature; CYP2D6;
D O I
10.1097/00008571-199606000-00001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To standardize CYP2D6 allele nomenclature, and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described, Based on recommendations for human genome nomenclature, we propose that alleles be designated by CYP2D6 followed by an asterisk and a combination of roman letters and arabic numerals distinct for each allele with the number specifying the key mutation and, where appropriate, a letter specifying additional mutations, Criteria for classification as a separate allele and protein nomenclature are also presented.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 50 条
  • [21] The frequencies of mutated alleles of CYP2D6 gene in a Turkish population
    Serin, A.
    Canan, H.
    Alper, B.
    Gulmen, M.
    FORENSIC SCIENCE INTERNATIONAL, 2012, 222 (1-3) : 332 - 334
  • [22] The relative activity of polymorphic CYP2D6 alleles is substrate dependendent
    Bogni, A
    Hartung, T
    Monshouwer, M
    Coecke, S
    DRUG METABOLISM REVIEWS, 2002, 34 : 149 - 149
  • [23] Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy
    Lyon, Elaine
    Foster, Julie Gastier
    Palomaki, Glenn E.
    Pratt, Victoria M.
    Reynolds, Kristen
    Sabato, M. Fernanda
    Scott, Stuart A.
    Vitazka, Patrik
    GENETICS IN MEDICINE, 2012, 14 (12) : 990 - 1000
  • [24] Identification of CYP2D6 impaired functional alleles in Mexican Americans
    Luo, HR
    Gaedigk, A
    Aloumanis, V
    Wan, YJY
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (11) : 797 - 802
  • [25] In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
    Hertz, Daniel L.
    Snavely, Anna C.
    McLeod, Howard L.
    Walko, Christine M.
    Ibrahim, Joseph G.
    Anderson, Steven
    Weck, Karen E.
    Magrinat, Gustav
    Olajide, Oludamilola
    Moore, Susan
    Raab, Rachel
    Carrizosa, Daniel R.
    Corso, Steven
    Schwartz, Garry
    Peppercorn, Jeffrey M.
    Evans, James P.
    Jones, David R.
    Desta, Zeruesenay
    Flockhart, David A.
    Carey, Lisa A.
    Irvin, William J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (05) : 1122 - 1130
  • [26] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [27] CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess
    von Ahsen, Nicolas
    Tzvetkov, Mladen
    Karunajeewa, Harin A.
    Gomorrai, Servina
    Ura, Alice
    Brockmoeller, Juergen
    Davis, Timothy M. E.
    Mueller, Ivo
    Ilett, Kenneth F.
    Oellerich, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS, 2010, 1 (04): : 310 - 319
  • [28] Identification of New Alleles and the Determination of Alleles and Genotypes Frequencies at the CYP2D6 Gene in Emiratis
    Qumsieh, Rula Y.
    Ali, Bassam R.
    Abdulrazzaq, Yousef M.
    Osman, Ossama
    Akawi, Nadia A.
    Bastaki, SalimM. A.
    PLOS ONE, 2011, 6 (12):
  • [29] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [30] Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice
    Tolledo, Cole
    Stocco, Marlaina R.
    Miksys, Sharon
    Gonzalez, Frank J.
    Tyndale, Rachel F.
    MOLECULAR NEUROBIOLOGY, 2020, 57 (06) : 2509 - 2520